Mass spectrometry combined approaches highlight a defect in proteasome 20S assembly in patients with neurological disorders

Abstract N°

Review committee

Sélectionnez le(s) utilisateur(s) chargé(s) de la revue de cet abstract.

Communication type

Speaker abstract
Oral presentation
Flash communication
Poster

Communication status

Accepted
Rejected

Final abstract N°

Note globale

Notification mail sent

Abstract theme *

The Scientific Committee may redirect an abstract to a theme it considers more appropriate, or even to a new theme not yet listed.

Abstract content *

Max 2000 characters. Line breaks are supported.

The 20S proteasome is an enzyme made of 14 highly conserved subunits α and β, that are successively assembled by chaperones. It represents the catalytic core of the ubiquitin-proteasome system, essential to maintain protein homeostasis and clearance. Over the past ten years, an increasing number of loss-of-function mutations have been identified in genes encoding for proteasome subunits in various patients that are clinically classified with a neurodevelopmental delay. This disease is referred to as Neurodevelopmental Disorders (NDD). To date, the molecular basis of this phenotype is not understood as it cannot be associated with specific proteasome genes.
We developed a strategy combining different mass spectrometry approaches. Our pipeline includes Bottom-Up and Top-Down analyses and allows, after immunopurification of 20S complexes, to investigate the interactome, composition, assembly, and PTMs of the proteasome. We applied this approach on T cells derived from patients and noticed a defect in 20S assembly in a NDD patient harboring a de novo mutation in PSMB3 gene. Indeed our data showed a striking increase in proteasome-associated chaperones revealing a stalling in proteasome assembly in these mutants. In this regard, we plan to dig deeper into this defect by producing mutated proteasomes via recombinant expression and to use structural MS to pinpoint more precisely at which step in assembly the mutations interfere and the effect they have on their structures.

Author(s) informations *

1	First name * Last name * email * Presenting author * At least and only one presenting author must be selected per abstract Presenting author Do you want this email to appear in the book of abstracts? If you refuse, only the administrators and the review commitee will have access to this email as part of the review process. YesNo Laboratory * Address * ZIP code * City * Country *
2	First name * Last name * email * Presenting author * At least and only one presenting author must be selected per abstract Presenting author Do you want this email to appear in the book of abstracts? If you refuse, only the administrators and the review commitee will have access to this email as part of the review process. YesNo Laboratory * Address * ZIP code * City * Country *
3	First name * Last name * email * Presenting author * At least and only one presenting author must be selected per abstract Presenting author Do you want this email to appear in the book of abstracts? If you refuse, only the administrators and the review commitee will have access to this email as part of the review process. YesNo Laboratory * Address * ZIP code * City * Country *
4	First name * Last name * email * Presenting author * At least and only one presenting author must be selected per abstract Presenting author Do you want this email to appear in the book of abstracts? If you refuse, only the administrators and the review commitee will have access to this email as part of the review process. YesNo Laboratory * Address * ZIP code * City * Country *
5	First name * Last name * email * Presenting author * At least and only one presenting author must be selected per abstract Presenting author Do you want this email to appear in the book of abstracts? If you refuse, only the administrators and the review commitee will have access to this email as part of the review process. YesNo Laboratory * Address * ZIP code * City * Country *
6	First name * Last name * email * Presenting author * At least and only one presenting author must be selected per abstract Presenting author Do you want this email to appear in the book of abstracts? If you refuse, only the administrators and the review commitee will have access to this email as part of the review process. YesNo Laboratory * Address * ZIP code * City * Country *
1	First name * Last name * email * Presenting author * At least and only one presenting author must be selected per abstract Presenting author Do you want this email to appear in the book of abstracts? If you refuse, only the administrators and the review commitee will have access to this email as part of the review process. YesNo Laboratory * Address * ZIP code * City * Country *

Add another author

Are you an ECR? *

<7 years after last degree

Yes
No

Are you a Junior PI? *

If you have started your own group less than 3 years ago and are not chosen by the scientific committee for a talk, you will have the opportunity to give a keynote during an ECR parallel session

Yes
No

Are you an invited speaker? *

Yes
No

Consent *

By submitting this form I agree
- that the administrators use my personal information for the abstract revision process.
- that my name, affiliation and abstract content may be publicly displayed.

Captcha

Validate Email